1/13
07:00 am
avir
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference
1/8
07:00 am
avir
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/18
05:05 pm
avir
Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process
Low
Report
Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process
12/16
05:00 am
avir
Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships
Medium
Report
Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships
12/11
08:08 am
avir
Convergent Therapeutics Appoints Barbara Duncan to Board of Directors [Yahoo! Finance]
Low
Report
Convergent Therapeutics Appoints Barbara Duncan to Board of Directors [Yahoo! Finance]
12/4
03:20 pm
avir
After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study [Yahoo! Finance]
Low
Report
After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study [Yahoo! Finance]
12/4
07:15 am
avir
Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV) [Yahoo! Finance]
High
Report
Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV) [Yahoo! Finance]
12/4
07:00 am
avir
Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV)
High
Report
Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV)
11/26
07:00 am
avir
Atea Pharmaceuticals to Present and Provide a Business Update at the 7th Annual Evercore HealthCONx Conference
Low
Report
Atea Pharmaceuticals to Present and Provide a Business Update at the 7th Annual Evercore HealthCONx Conference
11/22
11:44 am
avir
Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]